Insights

Pharmaceutical
Insight MAY 8, 2026
The Reality Behind AstraZeneca’s £300m UK “Win”
Industry Trends
Insight MAY 4, 2026
The Life Sciences Industry in the New Era of Cybersecurity
Pharmaceutical
Insight MAY 1, 2026
Could a Daily Pill Replace Ozempic? The Race to Make Weight-Loss Drugs Easier to Take
Pharmaceutical
Insight APRIL 27, 2026
Novo Nordisk’s Integration of OpenAI
Industry Trends
Insight MARCH 27, 2026
Meningitis B Vaccine Shortage: Why it Happens
Industry Trends
Insight MARCH 23, 2026
Government Goodwill as a Competitive Edge: Strategic Takeaways from South Korea’s Pharma Partnerships
Industry Trends
Insight MARCH 13, 2026
How the Iran Conflict Could Disrupt Global Pharmaceutical Supply Chains
Market Trend
Insight MARCH 9, 2026
The Legal Logic Behind Big Pharma's MASH Buying Spree
M&A
Insight MARCH 6, 2026
The Push Toward Oral Obesity and Diabetes Biologics
M&A
Insight MARCH 2, 2026
Eli Lilly Strengthens In Vivo Platform with Orna Therapeutics Acquisition
Clinical Trials
Insight FEBRUARY 27, 2026
Why Phase II Trials Break More Biotech Companies Than Bad Science
Market Trend
Insight FEBRUARY 23, 2026
Pharma's Big Bet on Sports Advertising: Lessons from the Super Bowl and Olympics
Market Trend
Insight FEBRUARY 20, 2026
Alzheimer's Therapeutics: Renewed Investment and Emerging Opportunities
Pharmaceutical
Insight FEBRUARY 9, 2026
Skinny labels – the cause of disputes between drug makers
Market Trend
Insight FEBRUARY 6, 2026
Operational Decisions Becoming Strategic Signals in Biotech
Market Trend
Insight FEBRUARY 2, 2026
AstraZeneca’s Asia Gamble
Case Study
Insight JANUARY 30, 2026
US–UK Pharma Deal Reprices the UK Market
Case Study
Insight JANUARY 26, 2026
How a Biological Database Company Sells Electronic Shovels in the AI Gold Rush
Pharmaceutical
Insight DECEMBER 12, 2025
New EU Drug Rules: A Game-Changer for Start-Ups
Pharmaceutical
Insight DECEMBER 8, 2025
Novo Nordisk’s Path Through Recent Challenges
Case Study
Insight DECEMBER 1, 2025
Flagship Pioneering: Reinventing Venture Capital in Biopharma
Market Trend
Insight NOVEMBER 28, 2025
Fruit Flies in Drug Discovery: Faster, Cheaper, Smarter Early Screening
Case Study
Insight NOVEMBER 24, 2025
How Eli Lilly reached a $1 Trillion Valuation
M&A
Insight NOVEMBER 21, 2025
Johnson & Johnson's Acquisition of Halda Therapeutics: Expanding Precision Oncology Capability
M&A
Insight NOVEMBER 17, 2025
Pfizer-Novo-Metsera dispute: lessons to learn on biotech-pharma M&A deals
BioTech
Insight NOVEMBER 14, 2025
How AI and Automation are Opening the Door to Biotech Innovators
Case Study
Insight NOVEMBER 10, 2025
Brexit and the UK Biopharma Industry
Spin-Offs
Insight NOVEMBER 7, 2025
Kimberly-Clark's $32 Billion Acquisition of Kenvue: A Strategic Realignment in Global Healthcare
Market Trend
Insight NOVEMBER 3, 2025
Why Pharma Companies are Investing in U.S. Direct-to-Consumer Sales: Insights on Pharmaceutical Distribution
BioTech
Insight OCTOBER 31, 2025
Gut Instincts: How Microbiome Science Can Reshape Addiction Medicine
Case Study
Insight OCTOBER 27, 2025
Haleon’s Success Three Years After Leaving GSK
Spin-Offs
Insight OCTOBER 24, 2025
Johnson & Johnson's DePuy Synthes Spin-Off
Case Study
Insight OCTOBER 20, 2025
Three FDA Rejections Later: The Lessons Behind Xspray Pharma’s Dasynoc™ Setback
Pharmaceutical
Insight OCTOBER 14, 2025
GSK Enters a New Era Under Incoming CEO Luke Miels
BioTech
Insight OCTOBER 9, 2025
What to Take Away From Takeda's Discontinuation of Cell therapy?

Insights

The New Arms Race is Biological: Why Governments Are Betting Big on Biotechnology

Wallflowers and Bidding Wars: Small Biotech Deals in r/r Melanoma

'Heat Vaccination' As A Biopharmaceutical Opportunity

All Insights

The Reality Behind AstraZeneca’s £300m UK “Win”

The Life Sciences Industry in the New Era of Cybersecurity

Could a Daily Pill Replace Ozempic? The Race to Make Weight-Loss Drugs Easier to Take

Novo Nordisk’s Integration of OpenAI

Meningitis B Vaccine Shortage: Why it Happens

Government Goodwill as a Competitive Edge: Strategic Takeaways from South Korea’s Pharma Partnerships

How the Iran Conflict Could Disrupt Global Pharmaceutical Supply Chains

The Legal Logic Behind Big Pharma's MASH Buying Spree

The Push Toward Oral Obesity and Diabetes Biologics

Eli Lilly Strengthens In Vivo Platform with Orna Therapeutics Acquisition

Why Phase II Trials Break More Biotech Companies Than Bad Science

Pharma's Big Bet on Sports Advertising: Lessons from the Super Bowl and Olympics

Alzheimer's Therapeutics: Renewed Investment and Emerging Opportunities

Skinny labels – the cause of disputes between drug makers

Operational Decisions Becoming Strategic Signals in Biotech

AstraZeneca’s Asia Gamble

US–UK Pharma Deal Reprices the UK Market

How a Biological Database Company Sells Electronic Shovels in the AI Gold Rush

New EU Drug Rules: A Game-Changer for Start-Ups

Novo Nordisk’s Path Through Recent Challenges

Flagship Pioneering: Reinventing Venture Capital in Biopharma

Fruit Flies in Drug Discovery: Faster, Cheaper, Smarter Early Screening

How Eli Lilly reached a $1 Trillion Valuation

Johnson & Johnson's Acquisition of Halda Therapeutics: Expanding Precision Oncology Capability

Pfizer-Novo-Metsera dispute: lessons to learn on biotech-pharma M&A deals

How AI and Automation are Opening the Door to Biotech Innovators

Brexit and the UK Biopharma Industry

Kimberly-Clark's $32 Billion Acquisition of Kenvue: A Strategic Realignment in Global Healthcare

Why Pharma Companies are Investing in U.S. Direct-to-Consumer Sales: Insights on Pharmaceutical Distribution

Gut Instincts: How Microbiome Science Can Reshape Addiction Medicine

Haleon’s Success Three Years After Leaving GSK

Johnson & Johnson's DePuy Synthes Spin-Off

Three FDA Rejections Later: The Lessons Behind Xspray Pharma’s Dasynoc™ Setback

GSK Enters a New Era Under Incoming CEO Luke Miels

What to Take Away From Takeda's Discontinuation of Cell therapy?